wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37621250-03C8B6A5-90A5-48B9-B801-388C4AD68680
Q37621250-03C8B6A5-90A5-48B9-B801-388C4AD68680
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37621250-03C8B6A5-90A5-48B9-B801-388C4AD68680
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy.
P2860
Q37621250-03C8B6A5-90A5-48B9-B801-388C4AD68680
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37621250-03C8B6A5-90A5-48B9-B801-388C4AD68680
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3c182b89a25e2b3ae956b6db7d7e7759b092a0b2
P2860
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy.